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Abstract
Several lines of evidence over the last few years have been important in ascertaining that the 
pedunculopontine nucleus (PPN) region could be considered as a potential target for deep brain 
stimulation (DBS) to treat freezing and other problems as part of a spectrum of gait disorders in 
Parkinson disease and other akinetic movement disorders. Since the introduction of PPN DBS, a 
variety of clinical studies have been published. Most indicate improvements in freezing and falls in 
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patients who are severely affected by these problems. The results across patients, however, have 
been variable, perhaps reflecting patient selection, heterogeneity in target selection and differences 
in surgical methodology and stimulation settings. Here we outline both the accumulated 
knowledge and the domains of uncertainty in surgical anatomy and terminology. Specific topics 
were assigned to groups of experts, and this work was accumulated and reviewed by the executive 
committee of the working group. Areas of disagreement were discussed and modified accordingly 
until a consensus could be reached. We demonstrate that both the anatomy and the functional role 
of the PPN region need further study. The borders of the PPN and of adjacent nuclei differ when 
different brainstem atlases and atlas slices are compared. It is difficult to delineate precisely the 
PPN pars dissipata from the nucleus cuneiformis, as these structures partially overlap. This lack of 
clarity contributes to the difficulty in targeting and determining the exact localization of the 
electrodes implanted in patients with akinetic gait disorders. Future clinical studies need to 
consider these issues.
Keywords
Anatomy; Brainstem; Deep brain stimulation; Pedunculopontine nucleus; Parkinson disease
Gait disorders are a major source of disability in patients with akinetic movement disorders. 
Their anatomical basis and pathophysiology are poorly understood, and there is a need to 
further investigate the role of surgery in this field. The possible relevance of the 
pedunculopontine nucleus (PPN) region for movement disorders has been outlined by 
independent groups of investigators who demonstrated that there are degenerative changes in 
patients with advanced akinetic disorders such as Parkinson disease (PD), progressive 
supranuclear palsy and multiple systems atrophy [1–5]. More recent data indicate that 
cholinergic denervation due to degeneration of PPN neurons may underlie dopamine-
nonresponsive gait and balance impairment in PD [6, 7].
Several lines of evidence over the last few years have been important in ascertaining that the 
PPN region could be considered as a potential target for deep brain stimulation (DBS) to 
treat freezing and other problems as part of the spectrum of gait disorders in PD. In 1986, 
Mitchell et al. [8] had shown increased 2-deoxyglucose uptake reflecting increased synaptic 
activity in the PPN region of a primate rendered parkinsonian after MPTP (1-methyl-4-
phenyl-1,2,3,6-tetrahydropyridine) injections. The PPN receives GABAergic projections 
from the medial pallidum [9, 10], and therefore it has been assumed that PPN activity was 
reduced in the parkinsonian brain [9, 11]. Yet, this concept has been challenged by the 
known pathophysiology that the subthalamic nucleus (STN), which is excitatory and 
hyperactive in PD, also projects to the PPN. This latter pathway might account for the 
hyperactivity of PPN neurons projecting to the STN in rats with unilateral lesion of the 
substantia nigra [12]. In normal primates, high-frequency stimulation, radiofrequency and 
excitotoxic PPN lesions induced akinesia [13–17]. In MPTP-treated parkinsonian primates, 
however, low-frequency stimulation (25 Hz) and microinjections of bicuculline, a GABA 
antagonist, into the PPN reversed akinesia [17–20]. Recording of the midlatency auditory 
evoked P50 potential in PD patients concluded that the PPN was overactive in PD, and that 
bilateral pallidotomy normalized PPN output [21, 22].
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Since the introduction of the PPN area as a target for DBS in PD, a variety of studies have 
been published. Most indicate improvements in freezing and falls in patients that are 
severely affected by these problems. The results across patients, however, have been 
variable, perhaps reflecting patient selection, heterogeneity in target selection and 
differences in surgical methodology and stimulation settings. Therefore, we (E.M., J.K.K.) 
initiated an interdisciplinary task force in 2010 with the aim to explore in more detail the 
possible role of the PPN region as a target for DBS in PD. It was our goal to involve experts 
from different disciplines in the task force to reflect both diversity in opinion and in 
methodology. The task force became an official working group of the Movement Disorders 
Society (MDS) in 2012 with an executive committee consisting of three neurologists (E.M., 
B.R.B., M.S.O.) and three neurosurgeons (J.K.K., A.M.L., T.A.). In 2013, the president of 
the MDS at that time, Matthew Stern, and the president of the World Society for Stereotactic 
and Functional Neurosurgery (WSSFN), J.K.K., agreed that the working group would 
become a bisocietal endeavor, named the MDS Pedunculopontine Nucleus DBS Working 
Group in collaboration with WSSFN. The working group then planned to evaluate four 
different domains relevant to PPN DBS surgery in PD: preoperative selection of patients and 
available rating scales, clinical outcome and DBS programming, surgical anatomy, and 
surgical technique. It was decided that the first two papers would be submitted to a primarily 
neurological journal while the two latter papers would be submitted to a specialized 
neurosurgical journal. Here we outline both the accumulated knowledge and the domains of 
uncertainty in surgical anatomy and terminology. Issues relevant for surgical technique, side 
effects and postoperative imaging will be addressed in a companion paper.
Methodological Approach
In order to evaluate the details of both surgical anatomy and terminology of the PPN region 
relevant to DBS surgery, the executive committee formulated several questions during a 
consensus conference which were distributed to the co-authors of the paper. The PubMed 
database was searched using the following key words: pedunculopontine nucleus; deep brain 
stimulation; anatomy; physiology; surgery.
Specific topics were assigned to groups of authors, and this work was accumulated and 
reviewed by the executive committee of the working group. Areas of disagreement were 
discussed and modified accordingly until a consensus could be reached. The literature was 
continuously updated during that process.
Anatomy and Function of the PPN Region
The PPN, subcuneiform and cuneiform nuclei (CnF) comprise the mesencephalic locomotor 
region (MLR) [23–25]. This is a functional region from which electrical stimulation induces 
coordinated locomotion in decerebrate mammals [23, 24].
The PPN projects and receives projections from the STN, globus pallidus internus, and 
substantia nigra reticulata and compacta [26–28]. Further, it has afferent and efferent 
connections with the cerebellum, thalamus, cerebral cortex, and the spinal cord [9, 23].
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The PPN is also connected to catecholaminergic systems in the brainstem, such as the 
noradrenergic locus coeruleus [23, 29] and to serotonergic neurons of the dorsal raphe 
nucleus [30–32].
On the basis of its cytoarchitectural organization, the PPN has been subdivided into a pars 
dissipata and a pars compacta (fig. 1). Triple in situ hybridization studies determined that the 
profile of PPN neurons varies across its extent [33]. The PPN pars dissipata is located 
throughout the rostrocaudal extent of the PPN region and contains mainly small to medium-
sized GABAergic neurons. The PPN pars compacta is located in the caudal half of the 
nucleus and contains mostly cholinergic and glutamatergic cells [9, 11, 23, 34, 35]. In 
addition, cholinergic neurons of the PPN are also known as the Ch5 cholinergic cell group 
according to the classification of Mesulam et al. [36]. Similar to the PPN, the subcuneiform 
and cuneiform nuclei do not contain homogenous neuronal populations. Neurons of the CnF 
are mainly comprised of nitrinergic and GABAergic cells. These nuclei have no clear 
boundaries. This has led to some confusion concerning the overlap of functionally or 
anatomically defined regions in this area.
Experimental studies have shown that the PPN receives dopaminergic input from the 
substantia nigra compacta and ventral tegmental area [30, 37, 38]. Such inputs are 
modulated by NMDA, AMPA and GABAB receptors.
The PPN output controls the striatal loop, i.e. the STN, globus pallidus internus, and 
substantia nigra pars compacta. Other projections reach the intralaminar nuclei of the 
thalamus and nuclei of the lower brainstem. As such, the PPN occupies a strategic position 
between the limbic and striatal loops, and while it is mainly involved in locomotor activity 
[9, 11, 23, 34, 39–42], it is also potentially relevant in other domains including cognition and 
sleep. Together with the thalamic intralaminar nuclei, the PPN is part of the ‘ascending 
reticular activating system’ [9, 23, 43].
Both PPN and CnF have been suggested to influence muscle tone during the initiation of 
locomotion [44, 45]. Rodent studies have shown that MLR injections of the GABAA agonist 
muscimol completely abolish stepping. Because muscimol solely acts on neuronal cell 
bodies and not on passing axons, these results suggest that cells around the injection site (i.e. 
CnF and PPN) may be responsible for MLR-induced stepping [41]. A recent rodent study 
has shown that stimulation of the MLR markedly improves hind limb function in rats with 
incomplete spinal cord injury [46]. The integrative role of the PPN in human gait was 
demonstrated also by intraoperative and postoperative neurophysiological studies [47].
Considerations about the Terminology Used in PPN Anatomy
Since the description of the PPN by Jacobsohn [48] in 1909, the terminology used to label 
this nucleus has varied continuously. For instance, it has been labeled as ‘nucleus tegmenti 
pedunculopontinus’ [48], ‘pedunculopontine tegmental nucleus’ [49], ‘nucleus reticularis 
pedunculopontinus’ [50], ‘nucleus pedunculopontinus’ [51], ‘nucleus tegmenti 
pedunculopontinus’ [52, 53], ‘the area U’ [53–55], ‘the n nucleus’ [56], and ‘the PPTn of 
Kölliker’ [52] (the latter must be distinguished from the Kölliker-Fuse nucleus which now 
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refers to a subnucleus of the parabrachialis nucleus). Since there are so many differences in 
nomenclature, the terminology used across studies has not been consistent.
Anatomical Localization of the PPN in Brainstem Atlases
There is variability concerning the exact anatomical localization of the PPN across different 
brainstem atlases, in particular with regard to its borders [49, 50, 52, 53, 57]. It is commonly 
accepted that the PPN is bordered medially by the superior cerebellar peduncle (and its 
decussation) as well as the central tegmental tract (fig. 2). Anterior and lateral to the PPN is 
the lemniscal system, and caudal and rostral are the retrorubral field and substantia nigra 
reticulata, respectively. The posterior aspect of the PPN is contiguous with the lateral portion 
of the CnF.
Considering the cytoarchitectural characteristics of the pontomesencephalic reticular 
formation, the precise anatomical distinction between pontine and mesencephalic structures 
has always been open to debate. As a result, to define the rostrocaudal extent of the PPN 
some investigators have relied on the pontomesencephalic junction (PMJ), a line that 
connects the inferior aspect of the quadrigeminal plate (frenulum veli) posteriorly with the 
foramen caecum of the interpeduncular fossa anteriorly.
Reviewing different brainstem atlases with a focus on the PMJ as well as on the orientation 
of the slices in the transverse plane may provide a landmark for the rostrocaudal extent of 
the PPN in the human brainstem.
Cytoarchitecture of the Human Brainstem: Olszewski and Baxter
This atlas of brainstem structures provides an accurate description of the PPN and its 
subregions [52]. Caveats from a surgical perspective include that it is not based on 
stereotactic coordinates and that the transverse angle of sections is not exactly parallel to the 
PMJ. Two subdivisions of the PPN are distinguished: the pars dissipata and pars compacta. 
The PMJ slice is in plate No. XXVIII (cross-section No. 801) with no reference made to the 
PPN or the CnF. The next plate consists of a section 3 mm or 150 slices rostral (plate No. 
XXX; cross-section No. 651) that crosses the brainstem at the mid-portion of the inferior 
colliculus (IC) (fig. 3). In this section, the PPN pars dissipata and CnF are clearly delineated. 
Of interest, plate No. XXXI (cross-section No. 601), located 1 mm (50 slices) rostral to plate 
No. XXX and 4 mm rostral from the PMJ, contains the PPN pars compacta and dissipata, 
which is in contact with the CnF posteriorly. In this atlas, the PPN extends for 8 mm in the 
rostrocaudal axis, its most rostral extension reaching the level of the caudal border of the red 
nucleus (plate No. XXXIV, cross-section No. 401). The CnF and its subnuclei are 
represented as a large structure that extends from the PMJ (or just above it) to the level of 
the red nucleus.
Atlas of the Human Brainstem: Paxinos and Huang
Plates in this brainstem atlas are numbered based on distance from the obex [49]. The PMJ 
is represented in its figures 48 (obex + 31 mm) and 49 (obex + 32 mm), which contain the 
nucleus of the trochlear nerve, fibers of the trochlear nerve, their decussation, and the 
frenulum veli, just caudal to the infracollicular recess. The caudal aspect of the PPN pars 
Hamani et al. Page 5
Stereotact Funct Neurosurg. Author manuscript; available in PMC 2017 February 08.
 Europe PM
C Funders A
uthor M
anuscripts
 Europe PM
C Funders A
uthor M
anuscripts
dissipata is shown in its figure 48 (obex + 31 mm). The pars compacta is shown in its figure 
50 (obex + 33 mm), which also shows the pars dissipata at the level of the IC. According to 
the atlas, the pars compacta extends 4 mm rostrally but does not extend beyond the level of 
the IC. The PPN extends to the rostral pole of the IC (obex + 36 mm). Just above the PMJ, 
the CnF is located posterior to the PPN and extends to the caudal aspect of the superior 
colliculus. We note that in recent work, the authors have considerably changed this 
nomenclature [58].
Atlas for Stereotaxy of the Human Brain: Schaltenbrand and Wahren
In this atlas, the PPN is labeled as the nucleus tegmenti pedunculopontinus [53]. It is 
represented in coronal slices perpendicular to the anterior-posterior commissural plane at the 
level of the superior aspect of the superior cerebellar peduncle (plate 29). Axial slices of the 
rostral brainstem are presented in plate 57. The PPN per se is not labeled in those plates. 
Nevertheless, it may be included in the diffuse area labeled as griseum circumflexum brachii 
conjunctivi, which extends from the caudal mesencephalon to a region 5 mm below the PMJ.
Duvernoy’s Atlas of the Human Brainstem and Cerebellum: Naidich et al
This book [50] consists of a multimodal atlas of the brainstem based on magnetic resonance 
imaging. The PPN and CnF are described in several axial slices (P 84–89; P 329–330). 
Assumptions on the rostrocaudal extent of the PPN are difficult to conclude since the 
sections are not parallel to the PMJ.
The fact that most atlases rely on cytoarchitectural features may underestimate the extent of 
the PPN, since it is a diffuse reticular nucleus with indistinct borders. Using choline 
acetyltransferase immunohistochemistry, for example, Mesulam et al. [59] studied the extent 
of PPN cholinergic cells. They indicated that the caudal aspect of the PPN extends far below 
the level of the IC, whereas the PPN pars compacta could be observed as rostral as the 
decussation of the superior cerebellar peduncle. These findings were confirmed in a later 
study which provided more detail about the cholinergic cell group Ch5 within the PPN [1].
Two postmortem human studies found that sagittal sections were the most reliable for 
identifying the PPN in three dimensions. Labeling of cholinergic neurons showed that the 
pars compacta was located immediately dorsal to the brachium conjunctivum, with cells of 
the pars dissipata scattered within the brachium conjunctivum. The pars compacta was 
localized anterior/ventral to the posterior half of the IC, while the pars dissipata extended 
posteriorly and anteriorly below the PPN pars compacta [60, 61].
Conclusions
The PPN is a reticular nucleus with indistinct anatomical boundaries. Its long axis straddles 
the PMJ from the inferior collicular level to reach the rostral pons. The majority of its 
neurons lie lateral to the superior cerebellar peduncle and its decussation and the central 
tegmental tract, and medial to the curved band of the lemniscal system. It is evident that both 
the anatomy and the function of the PPN area will require further clarification. The extent of 
both the PPN and CnF does not exactly coincide when different brainstem atlases and atlas 
slices are compared. It is difficult to provide a precise delineation between the PPN pars 
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dissipata and the CnF, as these two structures partially overlap in the mesencephalic reticular 
formation.
The indistinct boundaries of this nucleus and the general lack of consensus in the field are 
important overall limitations, particularly with regard to PPN DBS surgery. This lack of 
clarity contributes to the difficulty in targeting and determining the exact localization of the 
electrodes implanted in human subjects suffering from neurodegenerative disorders.
We suggest that authors may use commonly accepted anatomical terms in future studies and 
reports. We advise also that reference should be made to the source which has been used to 
delineate the PPN. While the term ‘PPN’ would be appropriate when the nuclear core can be 
clearly identified, ‘PPN region’ might be used when this is not the case. To allow easier 
comparison of surgical results, we recommend to indicate whether the rostral or the caudal 
portion of the PPN is used for neuromodulation.
It is important to consider these issues when planning future studies in PPN DBS surgery, in 
particular with regard to developing a commonly accepted study protocol.
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Fig. 1. 
The PPN region at the level of the decussation of the superior cerebellar peduncles and the 
inferior colliculus (a) and at the level of the trochlear nucleus and the intercollicular area (b). 
The main nuclei are labeled on the left and the long fiber tracts on the right side. STT = 
Spinothalamic tract; CA = cerebral aqueduct; CN = cuneiform nucleus; CTT = central 
tegmental tract; Dec SCP = decussation of the superior cerebellar peduncles; LC = locus 
coeruleus; LL = lateral lemniscus; ML = medial lemniscus; MLF = medial longitudinal 
fasciculus; NRD = nucleus raphe dorsalis; PAG = periaqueductal gray; PN = pontine nuclei; 
PPNc = pedunculopontine nucleus pars compacta; PPNd = pedunculopontine nucleus pars 
dissipata; SNc = substantia nigra pars compacta; RST = rubrospinal tract; IV = trochlear 
nucleus; V = mesencephalic nucleus of the trigeminal nerve. Adapted from Fournier-
Gosselin et al. [35], with permission.
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Fig. 2. 
Functional mapping of PPN region: correlations between the structures in the vicinity of the 
PPN and their potential stimulation effects. An electrode positioned lateral to the PPN might 
be revealed by buzzing sounds (lateral lemniscus), unpleasant painful sensation and/or 
change in temperature sensation (spinothalamic tract), or paresthesias (medial lemniscus) 
when trial stimulation is applied. An anteromedial position could elicit the sensation of 
contralateral facial pulling or blinking (rubrobulbar tract) and/or mood changes (substantia 
nigra). A mediodorsal location could lead to oscillopsia, diplopia, or ocular deviation toward 
the side stimulated (medial longitudinal fascicle and trochlear nucleus), mandating careful 
inspection of extraocular movements. An electrode positioned dorsally could lead to a 
sensation of discomfort (periaqueductal gray), mandating that the stimulation be done with 
caution in the vicinity of the PPN. A dorsally placed electrode could also be noticed by jaw 
movements subjectively felt as pulling of masticatory muscles (mesencephalic nucleus of the 
trigeminal nerve). A nonspecific altered level of alertness (locus coeruleus) might also be 
observed. PPN = Pedunculopontine nucleus; Dec SCP = decussation of the superior 
cerebellar peduncles; SNc = substantia nigra pars compacta. Adapted from Fournier-
Gosselin et al. [35], with permission.
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Fig. 3. 
Plates XXX and XXXI of Cytoarchitecture of the Human Brain Stem published by J. 
Olszewski and D. Baxter [52]. The PPN pars dissipata is labeled as Tg. ds, and the PPN pars 
compacta is labeled as Tg. cm. The CnF is labelled as Cun. a Plate XXX: representation of 
cross-section 651. The plate contains the most caudal aspect of the PPN observable in the 
atlas. The posterior aspect of the brainstem is clearly located in the mesencephalon due to 
the presence of the IC. According to the distances between cross-sections, the posterior 
aspect is located 3 mm rostral to the PMJ (plate XXVIII in cross-section 801). b Plate 
XXXI: photomicrograph of cross-section 601 located 1 mm rostral to plate XXX. The plate 
contains the PPN pars compacta. Reprinted from Olszewski and Baxter [52], with 
permission.
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